Across Missouri and the nation, county jails have increasingly become the largest mental health providers in their communities. Facilities designed for short term detention are now routinely responsible for stabilizing individuals with serious mental illness, managing complex medication regimens, and preventing psychiatric crises, often without the funding structures, staffing models, or reimbursement systems available in traditional health care settings. As a result, county jails are absorbing a growing share of mental health treatment costs that were never intended to fall on local governments.
Over the past five years, this shift has translated into a substantial increase in both the usage and cost of prescription medications in county jails across the United States. National correctional health data indicate that pharmaceutical spending in local jails has increased by an estimated 30 to 50 percent since 2019, significantly outpacing general inflation and overall jail operating cost growth. In many jurisdictions, medications now account for approximately 20 to 25 percent or more of total jail health care expenditures, reflecting a nationwide increase in the medical complexity of individuals in custody.
A significant contributor to this trend is the rising prevalence and treatment intensity of mental health conditions within jail populations. National data consistently shows that more than 40 percent of individuals held in local jails have a diagnosed mental health condition, a rate several times higher than that of the general population. In response, jails have seen increased reliance on psychotropic medications, including antidepressants, mood stabilizers, antipsychotics, and long-acting injectable medications. These treatments are often clinically necessary to stabilize individuals in custody and maintain safety within facilities, but they can cost hundreds or thousands of dollars per patient each month. Long-acting injectable antipsychotics in particular have become more common due to their effectiveness in reducing behavioral incidents and ensuring medication continuity, yet they represent one of the fastest growing segments of jail pharmacy spending.
This national pattern is clearly reflected in local jail pharmacy data. While the majority of pharmacy expenses in 2020 and 2021 for the Cape Girardeau County Sheriff’s Office were absorbed through a broader medical service contract, direct pharmacy costs became more transparent beginning in 2022. Since that time, total pharmacy expenditures have increased sharply from $34,583.26 in 2022 to $77,301.62 in 2025, representing an increase of approximately 124 percent in nominal dollars over a three-year period. A growing share of this increase is attributable to mental health medications, as the jail population has demonstrated higher rates of serious mental illness requiring ongoing and often costly pharmaceutical management.
In 2022, the Cape Girardeau County Jail incurred $34,583.26 in total pharmacy charges, while only $829.14 was collected from incarcerated individuals, representing approximately 2.4 percent of total medication costs. As mental health prescribing expanded and overall drug prices increased, pharmacy costs rose to $51,844.68 in 2023. During that same year, inmate payments increased to $13,110.63, covering 25.3 percent of total costs. Despite this increase, the county remained responsible for nearly three quarters of all pharmacy expenditures, including the majority of mental health medication costs that cannot ethically or legally be withheld.
The trend continued in 2024, with pharmacy expenditures increasing to $54,405.21 and inmate collections totaling $16,665.44, or 30.6 percent of total costs. In 2025, pharmacy spending rose again to $77,301.62, reflecting a year over year increase of approximately 42 percent, while inmate payments increased to $21,803.86. However, the percentage of costs recovered declined slightly to 28.2 percent, underscoring that rising medication expenses, particularly for mental health treatment, continue to outpace the financial capacity of individuals in custody.
The growing cost of mental health medications presents unique challenges for jail administrators. Unlike some acute medical treatments that can be delayed, psychiatric medications often must be continued immediately upon intake to prevent decompensation, suicide risk, or behavioral crises. Interruptions in mental health treatment frequently result in increased use of segregation, emergency medical interventions, hospital transports, and staff time, all of which carry additional financial and operational costs. As a result, jails are often compelled to absorb higher pharmacy expenses to maintain safety, compliance, and constitutionally required standards of care.
The broader consequences of inadequate access to mental health medications extend beyond jail budgets. National research consistently demonstrates that untreated or under treated mental illness is closely associated with higher rates of disciplinary incidents, recidivism, and difficulty with successful community reentry. Given that more than 95 percent of individuals held in jails will eventually return to their communities, gaps in mental health treatment during incarceration contribute to increased strain on emergency rooms, community mental health providers, and law enforcement agencies after release.
In addition to public health and public safety concerns, counties face significant legal and financial exposure related to mental health care in custody. Courts have repeatedly affirmed that individuals in custody have a constitutional right to adequate medical and mental health treatment. Litigation arising from delayed or denied psychiatric care, medication interruptions, or failures in suicide prevention can result in costly settlements, federal oversight, and long-term compliance obligations. In many cases, the financial consequences of litigation far exceed the cost of providing appropriate and timely medication management.
Taken together, both national trends and local data demonstrate that rising pharmacy costs, driven in large part by increasing mental health treatment needs, represent a structural and ongoing challenge for county jails. While inmate copays have increased in total dollar amounts, they offset only a limited portion of overall expenditures and may create barriers to care without providing meaningful budget relief. Addressing these challenges will require long term funding strategies, data informed medication management, and policy approaches that recognize mental health treatment as a critical component of correctional health, public safety, and community well-being.
Estimated Pharmacy Cost Growth Based on Recent Trends
Based on recent pharmacy spending patterns and consistent with national correctional health data, pharmacy costs are expected to continue rising over the next three to five years. These estimates are illustrative and are intended to reflect recent trends rather than serve as a predictive budget model. From 2022 to 2025, total pharmacy expenditures increased from $34,583.26 to $77,301.62, representing an average annual growth rate of approximately 30 percent. While year to year increases may vary, even more conservative growth assumptions suggest a sustained and significant budget impact.
Using a conservative annual growth estimate of 12 percent, total pharmacy costs would be expected to reach approximately $86,600 in 2026, $97,000 in 2027, and $108,700 by 2028. Under a moderate growth scenario of 15 percent annually, pharmacy costs could increase to approximately $88,900 in 2026, $102,200 in 2027, and $117,500 by 2028. If recent higher growth patterns persist, particularly due to increased utilization of mental health medications and high cost specialty drugs, total pharmacy expenditures could exceed $130,000 within five years.
Mental health medications are expected to account for a growing share of these projected costs. National correctional health analyses indicate that psychotropic medications represent one of the fastest growing components of jail pharmacy spending, driven by higher prevalence of serious mental illness, increased use of long-acting injectable medications, and clinical standards requiring continuity of care upon intake. As a result, relatively small increases in the number of individuals requiring psychiatric stabilization can lead to disproportionate increases in overall pharmacy expenditures.
Inmate payments are not expected to keep pace with projected cost growth. Although inmate contributions increased from $829.14 in 2022 to $21,803.86 in 2025, they still covered less than 30 percent of total pharmacy expenditures. Given limited inmate wages and policy constraints on copays, counties should anticipate absorbing approximately 70 to 75 percent of total pharmacy costs moving forward, regardless of overall spending increases.
By Richard S. Rushin S6 Jail Administrator, Cape Girardeau County Sheriff’s Office
